Artificial Intelligence in the Differential Diagnosis of Cardiomyopathy Phenotypes.
Riccardo CauFrancesco PisuJasjit S SuriRoberta MontisciMarco GattiLorenzo MannelliXiang-Yang GongLuca SabaPublished in: Diagnostics (Basel, Switzerland) (2024)
Artificial intelligence (AI) is rapidly being applied to the medical field, especially in the cardiovascular domain. AI approaches have demonstrated their applicability in the detection, diagnosis, and management of several cardiovascular diseases, enhancing disease stratification and typing. Cardiomyopathies are a leading cause of heart failure and life-threatening ventricular arrhythmias. Identifying the etiologies is fundamental for the management and diagnostic pathway of these heart muscle diseases, requiring the integration of various data, including personal and family history, clinical examination, electrocardiography, and laboratory investigations, as well as multimodality imaging, making the clinical diagnosis challenging. In this scenario, AI has demonstrated its capability to capture subtle connections from a multitude of multiparametric datasets, enabling the discovery of hidden relationships in data and handling more complex tasks than traditional methods. This review aims to present a comprehensive overview of the main concepts related to AI and its subset. Additionally, we review the existing literature on AI-based models in the differential diagnosis of cardiomyopathy phenotypes, and we finally examine the advantages and limitations of these AI approaches.
Keyphrases
- artificial intelligence
- big data
- heart failure
- machine learning
- deep learning
- cardiovascular disease
- left ventricular
- healthcare
- electronic health record
- atrial fibrillation
- high resolution
- working memory
- small molecule
- mass spectrometry
- single cell
- skeletal muscle
- cardiac resynchronization therapy
- type diabetes
- congenital heart disease